Lawrence Banks received his Degree in Science in 1981 and his PhD in Microbiology from Leeds University, UK in 1984. His term as Director-General of the ICGEB commenced on 1 July, 2019. Scientific Coordinator of the ICGEB from 2016 – June 2019 he has been Group Leader of the Tumour Virology Laboratory at ICGEB Trieste, Italy since 1990. From 1988-1990 he was an independent Research Scientist at the Ludwig Institute for Cancer Research in London, UK and from 1984-1988, Post-doctoral Fellow at the Imperial Cancer Research Fund in London, UK.
He is Editor of the Journal of Virology, FEBS Journal, Papillomavirus Research, PLoS One, Frontiers Cellular Infection and Microbiology and is on the Editorial Boards of Antiviral Therapy, Virus Research and Biological Chemistry. Since 2017 he has been running Awareness Workshops in Academic Institutions across the ICGEB constituency and has organised over 15 major international workshops on Human Papillomavirus, Molecular Biology of Leishmania and DNA Tumor Viruses.
He has served on Grant Review and PhD Examination Committees of numerous scientific organisations in Italy and abroad, including the Human Frontiers Science Program, DKFZ, and WHO IARC, and is Research Degree Coordinator in Italy for the Open University UK. His current research interest focuses on Human Papillomaviruses (HPVs), the causative agents of a number of human tumours, including cervical cancer, which is a major cause of cancer-related death in women in many parts of the developing world.
His research activity is funded internationally through grants from public and private bodies, including the “Associazione Italiana per la Ricerca sul Cancro” AIRC and the Wellcome Trust. He has published over 220 papers in peer-reviewed, international journals.
During his mandate he will focus on continuing to drive the Organisation’s transparent managerial structure, expanding interaction in the biotech sector in ICGEB Member States, advancing scientific research of the laboratories in Trieste, New Delhi and Cape Town and contributing to advanced education of young scientists to promote science and technology-intensive solutions to improve the quality of life.
Research Activity
Molecular biology of Human Papillomaviruses: virus entry pathways and induction of malignancy
In ICGEB, we are acutely aware that the major challenges lie in achieving equality for all and ensuring that no country or individual is left behind. Today, 8 March, marks International Women’s Day, and ICGEB is very proud of its achievements in supporting women in science.
As 2020 drew to a close, the amazing job by all of our colleagues in this incredibly challenging year was striking. ICGEB had continued to be active both scientifically and institutionally – acting as a beacon for Member States throughout this period.
The 11th China Medical Expo, held on 18 September 2020, was the perfect opportunity for the unveiling ceremony of the ICGEB Regional Research Centre in China Medical City, Taizhou.
Whilst COVID has impacted on many of us, much has also been achieved over the last six months; not least the successful completion of several PhDs, including the first by videoconference.
Last December, no one thought that Covid19 would be a major global crisis. By late January however, the picture was beginning to change and ICGEB scientists had the foresight to recognise the danger looming and began to prepare for research on coronaviruses.
Alessandro Marcello, Group Leader, Molecular Virology lab, together with a task force team established by the Region, has reached a first, major goal in the battle against coronavirus.